Milpharma SRL
Milpharma reported total assets of 502,955 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Aug 2026).
The score of Milpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets -3 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Milpharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 93,986 € | ||||
| Equity | 141,468 € | ||||
| Cash | 92,465 € | ||||
| EBITDA | 133,132 € | ||||
| Total assets | 502,955 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Aug 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
Milpharma's financial analysis
- Solvency28.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Milpharma
Milpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0681.995.815
- VAT number
- BE0681995815
- Peppol
- Registered · 0208:0681995815 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Oct 2017
- Registered office
- 3770 Riemst
- Latest accounts
- 2025 · filed on 05 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Milpharma (SRL) has been based in Riemst since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 93,986 € and equity of 141,468 €; its revenue is not published. Its solvency stands at 28.1%, below the median of its sector (44.2%).
Companies similar to Milpharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek DE VOS Retail sale of pharmaceutical products Leuven · balance sheet 511,031 €
- Pharmacie Pharmavie Gilly Retail sale of pharmaceutical products Charleroi · balance sheet 513,458 €
- BIO - Vitalpharma Retail sale of pharmaceutical products Antwerp · balance sheet 532,020 €
- Vaveo Retail sale of pharmaceutical products Antwerp · balance sheet 446,113 €
- License to care Retail sale of pharmaceutical products Duffel · balance sheet 702,743 €
- Proxypharma LLB Retail sale of pharmaceutical products La Bruyère · balance sheet 707,554 €
- Boeyckens Retail sale of pharmaceutical products Vilvoorde · balance sheet 713,576 €
- Pharmaflor Retail sale of pharmaceutical products Namur · balance sheet 831,466 €
Frequently asked questions about Milpharma
What is the revenue of Milpharma?
Milpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Milpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0681995815 for Milpharma, if the company is VAT-registered. Its company number (CBE) is 0681.995.815.
Where is the registered office of Milpharma?
According to the CBE register, the registered office of Milpharma is in 3770 Riemst.
What is the equity of Milpharma?
At the close of the 2025 financial year, the equity of Milpharma amounts to 141,468 €, a solvency of 28.1% of total assets.
Who manages Milpharma?
The register lists 2 active mandates at Milpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Milpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →